-

Recursion to Present at the 38th Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY--(BUSINESS WIRE)--Recursion, a digital biology company industrializing drug discovery, will present a company update at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday January 16 at 10 a.m. PT. Co-founder and CEO Chris Gibson, Ph.D. will provide an overview of Recursion along with an update on recent clinical and corporate milestones.

About Recursion

Recursion is a digital biology company industrializing drug discovery. Recursion does this by combining automation, artificial intelligence, machine learning, in vivo validation capabilities and a highly cross-functional team to discover novel medicines that expand our collective understanding of biology. Recursion’s rich, relatable database of 4 petabytes of biological images generated in-house on the company’s robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people’s lives. Recursion is proudly headquartered in Salt Lake City. Learn more at www.recursionpharma.com, or connect on Twitter and LinkedIn.

Contacts

Media Contact:

Amanda Guisbond
amanda.guisbond@recursionpharma.com

Industry:

Recursion

Release Summary
Recursion's Co-Founder and CEO Chris Gibson, Ph.D. will present a company update at the 38th Annual J.P. Morgan Healthcare Conference.
Release Versions
English
Hashtags
#biotech
#drugdiscovery
#machinelearning

Contacts

Media Contact:

Amanda Guisbond
amanda.guisbond@recursionpharma.com

More News From Recursion

Recursion Appoints Dr. Ramona Doyle as Chief Medical Officer

SALT LAKE CITY--(BUSINESS WIRE)--Recursion, a digital biology company industrializing drug discovery, today announced the appointment of Dr. Ramona Doyle as its Chief Medical Officer. Dr. Doyle will lead Recursion’s pipeline through clinical development programs, including its four assets progressing towards Phase 2 trials. “Ramona brings fantastic experience across a broad swath of clinical development activities. What I admire most, though, is that on top of her extraordinary intellectual hor...

Altitude Lab Brings New Generation of Biotech Development to Utah

SALT LAKE CITY--(BUSINESS WIRE)--Altitude Lab announced its first resident companies and opened applications for its breakthrough collaborative facility and program. Founded by Recursion and the University of Utah’s Center for Technology & Venture Commercialization (TVC), the incubator fills the critical role of finding, supporting, incubating and accelerating early-stage life science and health care companies in Utah. Altitude Lab is the first of its kind—a blended incubator/accelerator pr...

Recursion Posts Immune Mapping and Drug Discovery Resource and Releases New Image Datasets

SALT LAKE CITY--(BUSINESS WIRE)--Recursion, a digital biology company industrializing drug discovery, released a preprint on applying deep-learning-driven analysis of cellular morphology to develop a scalable “phenomics” platform. The preprint demonstrates the capabilities of Recursion’s platform to model complex immune biology and screen for new therapeutics. Despite incredible efforts by dedicated scientists around the globe, new drug approvals still come at a rate of many dozens per year at...
Back to Newsroom